Cargando…

Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy

BACKGROUND: The benefit of daily administration of Peanut (Arachis hypogaea) Allergen Powder‐dnfp (PTAH)—formerly AR101—has been established in clinical trials, but limited data past the first year of treatment are available. This longitudinal analysis aimed to explore the impact of continued PTAH t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez‐Rivas, Montserrat, Vereda, Andrea, Vickery, Brian P., Sharma, Vibha, Nilsson, Caroline, Muraro, Antonella, Hourihane, Jonathan O'B., DunnGalvin, Audrey, du Toit, George, Blumchen, Katharina, Beyer, Kirsten, Smith, Alex, Ryan, Robert, Adelman, Daniel C., Jones, Stacie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293305/ https://www.ncbi.nlm.nih.gov/pubmed/34320250 http://dx.doi.org/10.1111/all.15027

Ejemplares similares

APPEAL‐1: A multiple‐country European survey assessing the psychosocial impact of peanut allergy
por: DunnGalvin, Audrey, et al.
Publicado: (2020)

Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland
por: Tsoumani, Marina, et al.
Publicado: (2022)

APPEAL‐2: A pan‐European qualitative study to explore the burden of peanut‐allergic children, teenagers and their caregivers
por: DunnGalvin, Audrey, et al.
Publicado: (2020)

Should peanut allergy screening be introduced for all Irish children?
por: Kelleher, Maeve, et al.
Publicado: (2015)

The Emperor Has No Symptoms: The Risks of a Blanket Approach to Using Epinephrine Autoinjectors for All Allergic Reactions
por: Turner, Paul J., et al.
Publicado: (2016)

A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial
por: Kelleher, Maeve M, et al.
Publicado: (2012)

The Positive and Negative Affect Schedule — Food Allergy (PANAS-FA): Adaptation and psychometric properties()
por: Coelho, Gabriel Lins de Holanda, et al.
Publicado: (2021)

The food allergy COPE inventory: Adaptation and psychometric properties()
por: Coelho, Gabriel Lins de Holanda, et al.
Publicado: (2022)

Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
por: Lins de Holanda Coelho, Gabriel, et al.
Publicado: (2022)

Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Attitudes Towards Food Allergy Scale: Psychometric properties and associations with food allergy quality of life and anxiety
por: Lins de Holanda Coelho, Gabriel, et al.
Publicado: (2022)

Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol
por: Zurzolo, Giovanni A, et al.
Publicado: (2013)

Allergy to Peanuts imPacting Emotions And Life (APPEAL): the impact of peanut allergy on children, adolescents, adults and caregivers in France
por: Couratier, Pascale, et al.
Publicado: (2020)

Post hoc analysis examining symptom severity reduction and symptom absence during food challenges in individuals who underwent oral immunotherapy for peanut allergy: results from three trials
por: Blumchen, Katharina, et al.
Publicado: (2023)

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
por: Chebar Lozinsky, Adriana, et al.
Publicado: (2020)

Formula supplementation of breast-fed infants increases the incidence of cow’s milk protein allergy
por: Dunn Galvin, Gillian, et al.
Publicado: (2015)

A short simple tool to measure the impact of food allergy on patients in routine clinical practice; the Food Allergy Quality of Life Questionnaire, Parent Form 10 (FAQLQ-PF10)
por: Moynihan, Donal, et al.
Publicado: (2015)

Psychosocial and productivity impact of caring for a child with peanut allergy
por: Acaster, Sarah, et al.
Publicado: (2020)

Deriving health utility indices from a food allergy quality‐of‐life questionnaire
por: Chen, Gang, et al.
Publicado: (2021)

Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses
por: Logan, Kirsty, et al.
Publicado: (2022)

The patient’s perspective on precautionary labelling
por: DunnGalvin, Audrey
Publicado: (2011)

A new assessment tool to measure the socio-economic impact of food allergy on patients and parents: the Food Allergy Socio-Economic Questionnaire Short-Form (FASEQ-SF)
por: Morrissey, Eimear, et al.
Publicado: (2015)

Food allergy satisfaction with life scale: A complementary measure to health‐related quality of life
por: Coelho, Gabriel Lins de Holanda, et al.
Publicado: (2023)

O08 - Increased early life Transepidermal Water Loss (TEWL) values can predate atopic dermatitis in asymptomatic infants: results from the BASELINE study
por: Kelleher, Maeve, et al.
Publicado: (2014)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Evaluation of the measurement properties of the Brazilian version of two quality-of-life questionnaires in food allergy – for children and their parents()
por: Mendonça, Raquel Bicudo, et al.
Publicado: (2019)

Early life Transepidermal Water Loss (TEWL) values as a predictor of food allergy and sensitisation at 2 years: results from the BASELINE Study
por: Kelleher, Maeve, et al.
Publicado: (2015)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology
por: Lange, Lars, et al.
Publicado: (2014)

White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
por: Lange, Lars, et al.
Publicado: (2021)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

Defining the window of opportunity and target populations to prevent peanut allergy
por: Roberts, Graham, et al.
Publicado: (2023)

A 24‐h helpline for patients undergoing oral food immunotherapy: Lessons from Italian experience during the SARS‐CoV‐2 pandemic
por: Polloni, Laura, et al.
Publicado: (2023)

Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible
por: Glaumann, Susanne, et al.
Publicado: (2013)

Home‐based graded exposure to egg to treat egg allergy
por: Cotter, Sarah, et al.
Publicado: (2021)

Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines
por: Hourihane, Jonathan O’B., et al.
Publicado: (2021)

Peanut Allergy: An Overview
por: Al-Ahmed, Nasser, et al.
Publicado: (2008)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_019u7udif57rqgb8kjoq7f1t6g